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Certain low-abundancebacterial species, suchas the
periodontitis-associated oral bacterium Porphyro-
monas gingivalis, can subvert host immunity to
remodel a normally symbiotic microbiota into a dys-
biotic, disease-provoking state. However, such path-
ogens also exploit inflammation to thrive in dysbiotic
conditions. How these bacteria evade immunitywhile
maintaining inflammation is unclear. As previously
reported, P. gingivalis remodels the oral microbiota
into a dysbiotic state by exploiting complement.
Nowwe show that in neutrophilsP.gingivalisdisarms
a host-protective TLR2-MyD88 pathway via protea-
somal degradation of MyD88, whereas it activates
an alternate TLR2-Mal-PI3K pathway. This alternate
TLR2-Mal-PI3K pathway blocks phagocytosis, pro-
vides ‘‘bystander’’ protection to otherwise suscepti-
ble bacteria, and promotes dysbiotic inflammation
in vivo. This mechanism to disengage bacterial clear-
ance from inflammation required an intimate cross-
talk between TLR2 and the complement receptor
C5aR and can contribute to the persistence of micro-
bial communities that drive dysbiotic diseases.
INTRODUCTION
Dysbiosis, a state characterized by imbalances in the rela-
tive abundance or influence of microbial species within an
ecosystem, is emerging as a potential trigger of mucosal in-
flammatory disorders, such as inflammatory bowel disease,
colorectal cancer, bacterial vaginosis, and periodontitis (Eloe-
Fadrosh and Rasko, 2013; Hajishengallis et al., 2012). Themech-
anisms leading to dysbiosis are poorly understood and hence
under intensive investigation. In this regard, the keystone-path-768 Cell Host & Microbe 15, 768–778, June 11, 2014 ª2014 Elsevierogen hypothesis holds that certain low-abundance pathogens
can subvert host immunity in ways that favor the remodeling
of a normally symbiotic microbiota into a dysbiotic and dis-
ease-provoking state (Hajishengallis et al., 2012; Stecher et al.,
2013).
For instance, the oral asaccharolytic bacterium Porphyromo-
nas gingivalis (Pg) fails to cause periodontitis in germ-free mice
despite colonizing this host; however, in conventional mice, Pg
transforms the periodontalmicrobiota into a dysbiotic community
andco-opts it to instigatedestructive inflammation (Hajishengallis
et al., 2011). In contrast, C5a receptor (C5aR; CD88)-deficient
mice are protected from Pg-induced dysbiosis and periodontitis
(Hajishengallis et al., 2011). The ability of Pg to instigate inflamma-
tory disease through community-wide supportive effects, while
being a low-abundance constituent of periodontitis-associated
biofilms in humans and animal models (Abusleme et al., 2013;
Hajishengallis et al., 2011), has prompted its designation as a
keystone pathogen (Hajishengallis et al., 2012).
Organisms involved in dysbiotic diseases are burdened with
the challenge of evading host immunity in an inflammatory envi-
ronment. In this respect, we hypothesized that the survival and
persistence of Pg is crucially dependent upon its capacity to
selectivelymanipulate the host response in ways that would sup-
press killing mechanisms but not inflammation. This is because
inflammation actually serves the nutritional needs of asac-
charolytic dysbiotic communities through the release of tissue
breakdown products including peptides and heme-containing
compounds (Hajishengallis, 2014). Therefore, although immuno-
suppression is a common immune evasion strategy of many
pathogens (Cyktor and Turner, 2011), it should not be a viable op-
tion for pathobionts that thrive on inflammation. However, the
molecular mechanism(s) by which immune-subversive bacteria
such as Pg can selectively inhibit immune elimination without
suppressing inflammation has remained obscure. Since neutro-
phils are heavily involved in the initiation and progression of
human periodontitis and compriseR95% of total leukocytes in
periodontal pockets where they constantly encounter Pg (Hajish-
engallis andHajishengallis, 2014; Nussbaum and Shapira, 2011),Inc.
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Figure 1. Pg Exploits C5aR and TLR2 In Vivo
to Inhibit Neutrophil Killing but Not Inflam-
mation
(A) Pg (109 CFU) was injected into implanted
chambers in mice, and recruited cells were
phenotypically characterized by flow cytometry.
The majority (>97%) were neutrophils (Ly6G+),
whereas macrophages (F4/80+) or T cells (CD3+)
were essentially absent.
(B and C) Pg (109 CFU) was injected into implanted
chambers in WT mice or in the indicated knockout
mice (with or without 10 mg C5aRA, iC5aRA con-
trol, anti-TLR2, or isotype control). Fluid was
aspirated from the chambers 2 hr postinoculation
and was used to determine viable Pg CFU (B) and
measure the indicated cytokine responses by
ELISA (C). Baseline levels (prior to Pg injection) for
TNF and IL-1b were undetectable; baseline levels
of IL-6 were <10% of the Pg-induced response
in WT.
(D) Pg and F. nucleatum (Fn) were injected either
alone (109 CFU) or together (5 3 108 CFU each)
into implanted chambers in WT mice or in the
indicated knockout mice. At 24 hr postinoculation,
chamber fluid was aspirated to determine viable CFU. In (B) and (D), each symbol represents an individual mouse and horizontal lines indicate means. In (C), data
are means ±SD (n = 5 to 6mice per group except for WT; n = 10mice). The experiments were performed twice yielding consistent results. *p < 0.05 and **p < 0.01
compared with untreated WT control ([B] and [C]) or between the indicated groups (D). NS, not significant. See also Figure S1.
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Uncoupling Bacterial Clearance from Inflammationwe addressed this issue in the context of Pg-neutrophil interac-
tions in vitro and in vivo. Our study dissected how P. gingivalis
subverts complement and Toll-like receptor (TLR) signaling to
inhibit bacterial killingwhile preserving inflammation andpromot-
ing dysbiosis in vivo.
RESULTS
Pg Inhibits the Killing but Not the Proinflammatory
Activity of Neutrophils In Vivo
The ability of Pg to persist and cause dysbiosis and periodontitis
inmice requires intact C5aR signaling (Abe et al., 2012; Hajishen-
gallis et al., 2011). Since neutrophils constitute the overwhelming
majority of professional phagocytes recruited to periodontal
pockets, we hypothesized that Pg exploits C5aR to inhibit
neutrophil killing but not neutrophil-mediated inflammation. To
address this hypothesis in a quantitative way, we used the
mouse chamber model (Burns et al., 2010; Mydel et al., 2006).
This model involves injectable inoculation of bacteria into the
lumen of a subcutaneously implanted titanium-coil chamber,
thereby allowing quantitative assessment of bacterial interac-
tions with recruited neutrophils (>97% of recruited leukocytes)
(Figure 1A). Since innate pattern recognition of Pg is predomi-
nantly mediated by TLR2 (Burns et al., 2010), which synergizes
with C5aR in periodontal inflammation (Abe et al., 2012), we
examined the interactions of Pg with both C5aR and TLR2 using
knockout mice or specific inhibitors.
At 2 hr postinoculation with Pg, chamber fluid aspirated from
mice lacking C5aR (C5ar/) or TLR2 (Tlr2/), or from wild-
type (WT) mice treated with C5aR antagonist (C5aRA) or anti-
TLR2, contained significantly lower Pg viable counts (CFU) as
compared with corresponding controls (i.e., WT mice that were
left untreated or treated with control compounds) (Figure 1B).
In contrast, Pg CFU counts recovered from the chambers ofCell Hmice lacking complement receptor 3 (CR3; CD11b/) did
not differ from those recovered from WT controls (Figure 1B).
These data suggested that both C5aR and TLR2 are required
for enhanced Pg survival in the chambers. Consistent with
this, a gingipain-deficient isogenic mutant (KDP128), which
cannot generate C5a to activate C5aR (Liang et al., 2011), was
extremely susceptible to killing unless C5a was added exoge-
nously, resulting in decreased phagocytosis (Figure S1 available
online). Interestingly, despite their increased capacity to clear
Pg, C5ar/ mice and C5aRA-treated WT mice recruited lower
numbers of neutrophils (typically 2.5 [±0.8] 3 106) as compared
to those in untreated WT mice (typically 1.0 [±0.3] 3 107),
whereas the recruitment of neutrophils in the chambers of
Tlr2/ mice and anti-TLR2-treated WT mice was not signifi-
cantly affected compared with untreated WT controls (data
not shown). No Pg viable counts could be recovered from blood
or internal organs (spleen, liver, lungs, and kidney) from WT
or knockout mice; similarly, quantitative real-time PCR of the
ISPg1 gene of Pg failed to detect Pg in those tissues.
Treatment of Tlr2/ mice with C5aRA (or, conversely, treat-
ment of C5ar/ mice with anti-TLR2) had no further inhibitory
effect on Pg viability compared to untreated Tlr2/ (or
C5ar/) mice (Figure 1B). This finding and the observation
that the survival of Pg is inhibited to the same extent regardless
of which of the two receptors (C5aR or TLR2) is lacking or
blocked collectively suggest that C5aR and TLR2 engage in
cooperative crosstalk to prevent Pg killing. This C5aR/TLR2-
dependent evasive mechanism is unlikely to involve generalized
neutrophil immunosuppression, since the induction of proin-
flammatory cytokines in the chambers was higher when both
C5aR and TLR2 were functional (WT mice) than when C5aR or
TLR2 signaling was ablated genetically (C5ar/ and Tlr2/
mice) or pharmacologically (C5aRA-treated and anti-TLR2-
treated WT mice) (Figure 1C).ost & Microbe 15, 768–778, June 11, 2014 ª2014 Elsevier Inc. 769
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Figure 2. Interactions of Pg with Human
Neutrophils
(A–C) In vitro killing ([A] and [B]) and oxidative burst
(C) assays using purified human neutrophils and
Pg in the presence of the indicated compounds.
In (A), mAbs to TLR2, CR3, CXCR4, and isotype
controls were used at 10 mg/ml; AMD3100,
1 mg/ml; C5aRA and iC5aRA control, each at 1 mM;
SQ22536, 200 mM; PKI 6-22, 1 mM; and H-89,
10 mM. In (B) and (C), exogenous C5awas added at
10 nM, whereas C5aRA and iC5aRA control were
each added at 1 mM.
(D and E) Neutrophil activation by Pg induces
C5aR-TLR2 coassociation.
(D) Human neutrophils were challenged with
Syto9-labeled Pg (green) for 30 min (MOI = 10:1)
followed by fixation and staining for C5aR (red) and
TLR2 (blue). Bottom right, merged image.
(E) Human neutrophils were challenged with Pg
(MOI = 10:1) for 10 min. FRET between the indi-
cated donors and acceptors was measured from
the increase in donor (Cy3) fluorescence after
acceptor (Cy5) photobleaching. All data are
means ±SD (n = 3) from one of at least two
experiments yielding similar results. The horizontal dashed line indicates the maximum (max) energy transfer efficiency in the experimental system determined as
the energy transfer between two different epitopes on the same molecule (C5aR). *p < 0.01 compared with untreated control (medium only) or between the
indicated groups.
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Uncoupling Bacterial Clearance from InflammationIn contrast to Pg, the periodontal and systemic pathogen
Fusobacterium nucleatum (Hajishengallis and Lamont, 2012;
Rubinstein et al., 2013) was susceptible to neutrophil killing in
the chambers of WT mice (Figure 1D, far left). Intriguingly, the
survival of F. nucleatum was remarkably enhanced by about 3
log10 units in coinfection experiments with Pg in WT but not in
C5ar/ or Tlr2/ mice (Figure 1D). Therefore, Pg can rescue
F. nucleatum in a C5aR- and TLR2-dependent manner.
Pg Induces C5aR-TLR2 Coassociation in Human
Neutrophils and Inhibits Their Killing Function
To test the potential human relevance of the C5aR/TLR2-depen-
dent evasion mechanism of Pg in mice, we performed receptor
blockade experiments in human neutrophils. The ability of hu-
man neutrophils to kill Pgwas significantly enhanced by blocking
C5aR or TLR2, but not other receptors such as CR3 or CXCR4
(Figure 2A), suggesting that intact C5aR and TLR2 signaling is
required for maximal protection of Pg against also human neu-
trophils. Unlike our previous findings with macrophages (Wang
et al., 2010), the mechanism underlying immune evasion of neu-
trophils did not involve cAMP-dependent protein kinase A (PKA)
signaling, since treatments with inhibitors of cAMP synthesis
(SQ22536) or of PKA (PKI 6-22 or H89) failed to influence the
capacity of neutrophils to kill Pg (Figure 2A).
Although C5a is produced endogenously in the cell-bacterial
cultures by direct enzymatic action of the Pg gingipains on C5
(Liang et al., 2011; Wang et al., 2010), exogenous addition of
extra C5a further inhibited neutrophil killing of Pg in a C5aR
(CD88)-dependent manner (Figure 2B). On the other hand,
exogenous C5a augmented the Pg-induced oxidative burst
in a C5aR-dependent manner (Figure 2C), suggesting that the
mechanism whereby Pg evades killing involves interference
with a subset of neutrophil responses rather than immune
paralysis.770 Cell Host & Microbe 15, 768–778, June 11, 2014 ª2014 ElsevierConfocal microscopy of Pg-stimulated human neutrophils
revealed colocalization of Pg with C5aR (Figure 2D), which
came into molecular proximity with TLR2 (but not TLR5 or
MHC Class I) in Pg-stimulated (but not resting) neutrophils, as
shown by fluorescence resonance energy transfer (FRET) (Fig-
ure 2E). This C5aR-TLR2 coassociation probably takes place in
lipid rafts, as there was significant energy transfer between these
receptors and the lipid raft marker GM1 (Figure 2E). In summary,
Pg interacts with and exploits C5aR and TLR2 in human neutro-
phils to enhance its survival. We next set out to dissect the
evasive mechanism(s) acting downstream of C5aR and TLR2.
Pg-Induced C5aR-TLR2 Crosstalk Leads to MyD88
Degradation
Despite being a TLR2 signaling adaptor (O’Neill and Bowie,
2007), MyD88 is unlikely to contribute to immune evasion medi-
ated by the Pg-induced C5aR-TLR2 crosstalk; indeed, MyD88
was shown to contribute to the clearance of Pg infection (Burns
et al., 2010). Accordingly, Pg exhibited enhanced survival in the
chambers of Myd88/ mice as compared with WT mice (Fig-
ure 3A, far left). We then investigated whether Pg can counteract
MyD88 and thereby achieve increased protection against neu-
trophils. Strikingly, Pg caused time-dependent reduction in the
levels of MyD88 protein but not mRNA (Figure 3B), suggesting
that Pg causes MyD88 degradation at least in vitro. The ability
of Pg to degrade MyD88 was completely reversed by C5aRA
or anti-TLR2 (Figure 3C), suggesting that degradation is medi-
ated by C5aR-TLR2 crosstalk. A TLR2 agonist, the synthetic
lipopeptide Pam3CSK4, failed to induce MyD88 degradation
(Figure 3B), suggesting that TLR2 activation by itself is not suffi-
cient for this effect. However, Pam3CSK4 together with C5a did
induce MyD88 degradation, reproducing the phenotype of Pg-
treated cells and confirming dependence on concomitant activa-
tion of TLR2 and C5aR for MyD88 degradation (Figure S2A).Inc.
Figure 3. Pg Causes a Reduction in the Levels of MyD88, which Promotes Bacterial Killing
(A) Pg (109 CFU) was injected into implanted chambers in WTmice or in the indicated knockout mice (with or without 10 mg C5aRA, iC5aRA control, anti-TLR2, or
isotype control). Fluid was aspirated from the chambers 24 hr postinoculation and was used to determine viable Pg CFU.
(B–E) Pg was incubated in vitro with human neutrophils (MOI = 10:1) for the indicated times, and immunoblotting of neutrophil lysates was used to monitor the
levels of MyD88 protein (or b-actin; control). In (B), Pg was compared with Pam3CSK4 (10 ng/ml), and their effects on MyD88 were monitored also at the mRNA
level using real-time PCR. In (C), neutrophils were stimulated with Pg in the presence of C5aRA or iC5aRA control (each at 1 mM) or anti-TLR2 mAb or isotype
control (10 mg/ml). In (D), cell lysates immunoprecipitated using anti-MyD88 were probed with antibodies to MyD88 or to ubiquitin. In (E), neutrophils were
stimulated with Pg in the presence of increasing concentrations of epoxomycin.
(F) ATRA-HL-60 neutrophils were transfected with siRNA to Smurf1 and treated with Pg (MOI = 10:1) for 8 hr. Whole-cell-lysate immunoblotting with specific
antibodies was used to monitor the levels of Smurf1 and MyD88 protein (b-actin was used as control). Cell lysates immunoprecipitated using anti-MyD88 were
immunoblotted with anti-ubiquitin.
(G) Human neutrophils were treated with Pg and assayed for MyD88 degradation and ubiquitination as in (F) in the absence or presence of anti-TGF-b mAb.
(H) The indicated bacteria or compounds were injected (Pg, 109 CFU; Pam3SK4, 10 mg; F. nucleatum, 109 CFU) into implanted chambers in mice for the indicated
times, and immunoblotting of neutrophil lysates was used to monitor the levels of MyD88 protein.
(I) Assay for in vitro killing of Pg by purified mouse neutrophils of the indicated genotypes. All experiments were performed two (A) or three times ([B]–[I]) yielding
similar findings. In (A), each symbol represents an individual mouse, and horizontal lines indicate means. In (I), data aremeans ±SD (n = 4). *p < 0.05 and **p < 0.01
compared with WT control or between the indicated groups. IB, immunoblotting; IP, immunoprecipitation; WCL, whole-cell lysates. See also Figure S2.
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Uncoupling Bacterial Clearance from InflammationMoreover, Pg induced ubiquitination of MyD88, which correlated
temporally with reduced MyD88 protein levels (Figure 3D). This
observation suggested that the reduction in MyD88 protein
levels was mediated by ubiquitin-proteasome degradation, a
notion supported by the reversal of Pg-induced degradation of
MyD88 by the proteasome inhibitor epoxomycin (Figure 3E).
Pg caused C5aR- and TLR2-mediated and ubiquitin-protea-
some-dependent degradation of MyD88 also in all-trans retinoic
acid (ATRA)-differentiated HL-60 neutrophils (Figures S2B–
S2G), thus validating the use of these cells as a model of Pg
exploitation of human neutrophils. Using a siRNA approach
and ATRA-HL-60 cells, we have shown that Pg-induced ubiqui-
tination and degradation of MyD88 requires the E3 ubiquitin
ligase Smad ubiquitin regulatory factor 1 (Smurf1). Indeed,Cell Hwhen Smurf1 protein expression was diminished by siRNA
to Smurf1, the ability of Pg to degrade MyD88 was suppressed
(Figure 3F). Consistently, diminished expression of Smurf1 due
to specific siRNA treatment resulted in reduced ubiquitination
of MyD88 in Pg-treated cells (Figure 3F). In contrast to Smurf1,
other E3 ubiquitin ligases involved in the regulation of TLR
signaling pathways (Triad3A and Pellino-1) were shown to not
be involved in Pg-induced ubiquitination and degradation of
MyD88 (Figure S2H). Our investigation of Smurf1 was prompted
by our findings that transforming growth factor-b1 (TGF-b1), a
cytokine shown to cause ubiquitin-proteasome degradation
of MyD88 via Smurf1 (Lee et al., 2011), was induced in Pg-
challenged neutrophils in a C5aR/TLR2-dependent manner
(Figure S2I). Consistently, antibody-mediated neutralization ofost & Microbe 15, 768–778, June 11, 2014 ª2014 Elsevier Inc. 771
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Uncoupling Bacterial Clearance from InflammationTGF-b abrogated the ability of Pg to ubiquitinate and degrade
MyD88 (Figure 3G).
Importantly, Pg (but not Pam3CSK4) induced degradation
of MyD88 also in vivo, as shown by examining neutrophils har-
vested from Pg-inoculated mouse chambers (Figure 3H). In
contrast, F. nucleatum, which is susceptible to neutrophil killing
in the chambers (Figure 1D), failed to induceMyD88 degradation
(Figure 3H). Neutrophils purified from the bone marrow of
Myd88/ mice exhibited decreased killing activity against
Pg compared to WT controls, which in turn were less potent in
killing Pg than Tlr2/ or C5ar/ neutrophils (Figure 3I). There-
fore, although MyD88 contributes to neutrophil control of Pg,
the pathogen can counteract this host defense mechanism by
inducing degradation of MyD88.
MyD88-Independent Activation of PI3K Inhibits Pg
Phagocytosis and Induces Inflammation
The data in Figures 1–3 show that Pg evades both mouse and
human neutrophils through a common C5aR/TLR2-mediated
mechanism that involves MyD88 degradation. Therefore, find-
ings in the mouse chamber model are relevant to and predictive
of findings in the human system of Pg-neutrophil interactions.
We thus used the chamber model to obtain additional mecha-
nistic insights on how Pg manipulates neutrophils in vivo.
Although Pg exhibited enhanced survival in the genetic absence
of MyD88, treatments with C5aRA or anti-TLR2 promoted the
killing of Pg in the chambers of Myd88/ mice and diminished
its viable counts to levels similar to those seen in the chambers
of C5ar/ or Tlr2/ mice (Figure 3A). This finding suggested
that C5aR and TLR2 promote the survival of Pg also via a
MyD88-independent mechanism(s). In this regard, treatment of
mice with the phosphatidylinositol-3-OH kinase (PI3K) inhibitor
LY294002 (but not with the inactive analog LY303511) resulted
in significant reduction of Pg CFU counts (Figure 4A) to levels
comparable to those seen after inhibition of C5aR or TLR2
signaling (Figure 1B). The increased killing of Pg in the presence
of LY294002 was not associated with changes in the numbers of
recruited neutrophils (Figure 4B) andwas attributed to promotion
of phagocytosis (Figure 4C). In contrast, LY294002 had no signif-
icant effect on the phagocytosis of F. nucleatum (Figure S3A).
C5aRAor anti-TLR2 treatment enhancedPgphagocytosis in vivo
(in the chambers, Figure 4C) and in vitro (in Pg-neutrophil cul-
tures, Figure S3B) comparably to LY294002, suggesting that
PI3K may be acting as an effector of a signaling crosstalk be-
tween C5aR and TLR2. Indeed, maximal activation of PI3K (Tyr
phosphorylation of its p85 regulatory subunit) by Pg in purified
mouse neutrophils required the presence of both C5aR
and TLR2, although it was essentially independent of MyD88
(Figure 4D, left). Stimulation of neutrophils with both Pam3CSK4
and C5a caused considerably higher PI3K activation compared
to each ligand alone, thereby reproducing the phenotype
obtained by Pg and confirming dependence on TLR2 and
C5aR for synergistic PI3K activation (Figure 4D, right). Consis-
tent with the notion that PI3K is an effector of the subversive
C5aR-TLR2 crosstalk, the capacity of Pg to protect F. nucleatum
against neutrophil killing in coinfection experiments was abro-
gated in the presence of LY294002 (but not LY303511) (Fig-
ure 4E), as seen earlier in the absence of C5aR or TLR2 signaling
(Figure 1D).772 Cell Host & Microbe 15, 768–778, June 11, 2014 ª2014 ElsevierGiven that the in vivo host response to Pg is MyD88-indepen-
dent (Burns et al., 2010), we hypothesized that PI3K acts down-
streamofC5aRand TLR2 to promote inflammation.We therefore
assessed induction of proinflammatory cytokines (IL-1b, IL-6,
and TNF) in the chambers of Pg-inoculated WT mice in the pres-
ence of LY294002 or LY303511 control. LY294002 (but not
LY303511) inhibited the inflammatory responses, thereby impli-
cating PI3K in the process (Figure 4F). A similar but less pro-
nounced PI3K-depedent effect was observed when Pam3CSK4
was injected in the chambers in lieu of Pg (Figure S3C).
The mechanism by which the C5aR-TLR2-PI3K pathway
inhibited Pg phagocytosis involved inhibition of actin polymeri-
zation, a process required for phagocytosis. Indeed, C5aRA,
anti-TLR2, and LY294002 (but not their respective controls) pro-
moted Pg-induced actin polymerization (Figure 4G), suggesting
that Pg suppresses actin polymerization when the C5aR-TLR2-
PI3K pathway remains functional. Pg also suppressed the acti-
vation of RhoA (Figures 4H and S3D), a key regulator of actin
polymerization (Wiedemann et al., 2006). The ability of Pg to pre-
vent RhoA activation was counteracted by C5aRA, anti-TLR2,
and LY294002 (but not their respective controls), as shown by
an ELISA-based assay that measures the levels of GTP-loaded
RhoA (Figure 4H) or a related pull-down assay (Figure S3D).
Taken together, Pg inhibits phagocytosis by exploiting C5aR/
TLR2-dependent PI3K signaling, which suppresses RhoA acti-
vation and actin polymerization. Consistent with in vivo mouse
data (Figure 4F), LY294002 inhibited inflammatory cytokine re-
sponses by Pg-stimulated human neutrophils, as did treatments
with C5aRA or anti-TLR2 (Figure 4I). In summary, Pg escapes
phagocytic killing and induces inflammatory responses in neu-
trophils by activating PI3K in a way dependent upon C5aR and
TLR2 but not MyD88.
PI3K Mediates Periodontal Dysbiosis and Inflammation
The ability of Pg to cause dysbiosis and periodontitis requires
intact C5aR signaling (Abe et al., 2012; Hajishengallis et al.,
2011). In contrast to WT Pg, the KDP128 mutant that lacks
C5a-generating capacity failed to cause changes to the amount
and composition of the oral microbiota (Figure S4). Interestingly,
compositional shifts in the murine oral microbiota are not neces-
sarily associated with periodontal inflammation unless they are
accompanied by a significant increase in the bacteria load
(Eskan et al., 2012). To further characterize host signaling path-
ways involved in Pg-induced elevation of the total microbiota
counts and periodontal inflammation, Pg-colonized mice were
locally microinjected in the gingiva with various inhibitors, and
their effects on themicrobiota and host response were assessed
2 days later. The main purpose was to determine the role of PI3K
in dysbiotic inflammation in relation to C5aR and TLR2.We found
that LY294002 (but not LY303511) almost eliminated Pg from the
periodontal tissue (Pg numbers were decreased by 1.5 log10
units corresponding to 97% reduction) and reversed the in-
crease in the total microbial load induced by Pg colonization;
these effects were similar to those of C5aRA and anti-TLR2
(but not anti-TLR4, which had no effect) (Figure 5A). Moreover,
pharmacological inhibition of PI3K with LY294002 (but not with
LY303511 control) inhibited Pg-induced expression of inflamma-
tory cytokines in the periodontal tissue (at both the mRNA and
protein levels) (Figures 5B and 5C, respectively), as seen earlierInc.
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Figure 4. PI3K Promotes Inflammation and the Survival of Pg by Inhibiting Its Phagocytosis In Vivo
(A–C) Pg (109 CFU) was injected into implanted chambers in WT mice, with or without 10 mg LY294002 (PI3K inhibitor) or LY303511 (control). Fluid aspirated
from the chambers 2 hr postinoculation was used to determine viable Pg CFU (A), neutrophil recruitment (B), and Pg phagocytosis (C). In (C), the experiment
additionally included treatments with C5aRA, anti-TLR2, and respective controls (all at 10 mg).
(D) Activation of PI3K in mouse neutrophils after 15 min stimulation with Pg (left) or with 10 nM C5a and/or 100 ng/ml Pam3CSK4 (right) using FACE PI3Kp85
ELISA. In the left panel, neutrophils were from WT or indicated knockout mice.
(E) Pg and F. nucleatum (Fn) were injected either alone (109 CFU) or together (5 3 108 CFU each) into implanted chambers in WT mice with or without 10 mg
LY294002 or LY303511. At 24 hr postinoculation, chamber fluid was aspirated to determine viable CFU.
(F) Fluid aspirated from chambers 2 hr postinoculation with Pg was used to measure the indicated cytokine responses by ELISA.
(G) Changes in polymerized F-actin over time in human neutrophils exposed to Pg (MOI = 10:1) and treated with or without C5aRA or iC5aRA control (1 mM), anti-
TLR2 mAb or isotype control (10 mg/ml), or LY294002 or LY303511 (25 mM). Results are expressed as fold change relative to F-actin at baseline set as 1.
(H) Human neutrophils were treated as in (G), and after 20 min stimulation with Pg, the activation of RhoA was determined using the G-LISA RhoA assay kit. The
dashed line indicates baseline RhoA activation (in cells not exposed to Pg).
(I) Human neutrophils were treated as in (G), and after 6 hr-stimulation with Pg, the indicated cytokine responses were measured by ELISA. In (A) and (E), each
symbol represents an individual mouse, and horizontal lines indicate means. In bar graphs, data are means ±SD ([B], [C], and [F], n = 5; [D] and [G]–[I], n = 3). The
experiments were performed two ([A]–[C] and [E]–[H]) or three times ([D] and [I]), yielding consistent results. *p < 0.01 compared with control (WT or untreated) or
between the indicated groups. NS, not significant. See also Figure S3.
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et al., 2012; Hajishengallis et al., 2011; Liang et al., 2011). Taken
together, our findings are consistent with the notion that PI3K is
an effector of the subversive C5aR-TLR2 crosstalk that protects
Pg and contributes to dysbiotic inflammation.
Mal Is a Component of the C5aR-TLR2 Subversive
Pathway Acting Upstream of PI3K
MyD88-adaptor-like (Mal), another adaptor molecule involved in
TLR2 signaling, has been reported to bridgeMyD88 to the recep-Cell Htor complex but it can also interact with and activate PI3K
(Honda et al., 2012; Kagan and Medzhitov, 2006; O’Neill and
Bowie, 2007; Santos-Sierra et al., 2009). Therefore, it could not
be predicted whether Mal would have a host-protective role
similar to MyD88 or whether it would cooperate with the C5aR-
TLR2-PI3K subversive pathway. To determine the role of Mal
in neutrophil killing of Pg, we performed siRNA-mediated Mal
gene silencing in ATRA-differentiated HL-60 neutrophils. Treat-
ment with siRNA to Mal promoted the killing of Pg similarly to
C5aRA, anti-TLR2, or LY294002, whereas siRNA to MyD88ost & Microbe 15, 768–778, June 11, 2014 ª2014 Elsevier Inc. 773
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Figure 5. PI3K Promotes Dysbiotic Inflammation in the Periodontal
Tissue
(A–C) Mice were orally inoculated or not with Pg (109 CFU; three times at 2 day
intervals) and 7 days after the last inoculation were injected with the indicated
experimental or control compounds into the palatal gingiva, on the mesial of
the first molar and in the papillae between first and second and third molars on
both sides of themaxilla (1 ml of 1 mg per site; total of 6 mg in six sites). Two days
later, themicewere euthanized andmaxillary periodontal tissuewas harvested
to determine Pg and total bacterial numbers using real-time PCR (A) or was
used to measure the indicated cytokine responses at the mRNA (B) or protein
(C) level. The mRNA expression levels were normalized against GAPDHmRNA
and expressed as fold induction relative to the transcript levels of sham-in-
fected mice, which were assigned an average value of 1. Data are means ±SD
(n = 5 mice) from one of two experiments yielding consistent results. *p < 0.01
compared with untreated control (A) or with sham control ([B] and [C]); @p <
0.01 comparedwith Pg alone. No Pg could be detected in sham-infectedmice.
See also Figure S4.
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treated with control siRNA (Figure 6A). Moreover, siRNA to Mal
promoted Pg phagocytosis (Figure 6B), further suggesting that
Mal is a component of the immunoevasive pathway of Pg. Treat-
ments of ATRA-HL-60 cells with siRNA to Mal also inhibited
Pg-induced activation of PI3K (Figure 6C) and induction of proin-
flammatory cytokines (Figure 6D), suggesting that Mal acts up-
stream of PI3K. The immunoevasive and proinflammatory role
of Mal was confirmed by similar findings in mouse neutrophils
treated with a cell-permeable Mal inhibitor peptide (Figures
S5A–S5D) and also by genetic evidence using WT and Mal-defi-
cient neutrophils in the same assays (Figures S5E–S5I). More-774 Cell Host & Microbe 15, 768–778, June 11, 2014 ª2014 Elsevierover, MyD88/ neutrophils responded to Pg (monitored by
TNF production) in a strictly PI3K-dependent manner, whereas
MyD88/ macrophages failed to respond at all (Figure S5K).
These data further support the existence of a Pg-induced
MyD88-independent proinflammatory PI3K pathway in neutro-
phils. Coimmunoprecipitation analysis showed that PI3K associ-
ated with both TLR2 and Mal in Pg-activated ATRA-HL-60 cells
or primary human neutrophils (Figure 6E). In summary, Mal is an
essential component of the TLR2-PI3K subversive pathway that
inhibits Pg phagocytosis and killing while promoting inflamma-
tory responses.
DISCUSSION
Although neutrophils in the periodontal pockets of patients with
chronic periodontitis form a ‘‘defense wall’’ against the bacteria,
they largely fail to control bacterial growth and prevent dysbiosis
despite being viable and capable of immune responses (Ryder,
2010). In fact, periodontitis patients have a greater number of
and longer-lived neutrophils in the oral tissues compared with
healthy controls (Lakschevitz et al., 2013). Our findings provide
molecular explanation for the inability of human (and mouse)
neutrophils to control periodontal bacteria and prevent dysbiotic
inflammation. Specifically, we showed that Pg instigates a
crosstalk between C5aR and TLR2 to disarm and disassociate
a host-protective TLR2-MyD88 pathway from a proinflamma-
tory and immune-evasive TLR2-Mal-PI3K pathway (Figure 7).
Neutrophils exposed to Pg were impaired also in the clearance
of bystander bacterial species as long as Pg had access to func-
tional C5aR and TLR2, consistent with the capacity of Pg to
elevate the total microbiota counts in periodontal tissue with
intact C5aR and TLR2 signaling.
The subtle manipulation of the human neutrophil response by
Pg is probably the result of coevolution with the host, in which Pg
could persist only if its ability to evade killing would not interfere
with the inflammatory response. This is because periodontal
bacteria including Pg depend critically on an inflammatory envi-
ronment to obtain nutrients in the form of tissue-breakdown
products (e.g., peptides and heme-containing compounds)
(Hajishengallis and Lamont, 2014). Such bacteria are therefore
‘‘inflammo-philic’’ (from the Greek suffix philicmeaning attracted
to or loving). Consistent with this concept, the bacterial biomass
of human periodontitis-associated biofilms increases with
increasing periodontal inflammation (Abusleme et al., 2013),
and anti-inflammatory treatments in animal models suppress
the periodontal bacterial load (Eskan et al., 2012; Hasturk
et al., 2007; Moutsopoulos et al., 2014). This vital dependence
on inflammation could account for the radically different
behavior of Pg as compared with certain other major immune-
evasive bacteria such as Staphylococcus aureus. Whereas Pg
expresses virulence factors (gingipains) to proactively generate
C5a and activate C5aR (Liang et al., 2011; Wang et al., 2010),
S. aureus expresses a virulence factor (chemotaxis inhibitory
protein) to block C5aR activation (de Haas et al., 2004). More-
over, S. aureus expresses a leukotoxin that targets and kills neu-
trophils (Reyes-Robles et al., 2013), whereas Pg manipulates
but does not kill neutrophils. It could be speculated that inflam-
mophilic pathobionts in diverse disease settings (e.g., thriving
in gut dysbiosis and implicated in inflammatory bowel diseaseInc.
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Figure 6. Mal Is a Component of the C5aR-
TLR2 Subversive Pathway Acting Upstream
of PI3K
(A–D) ATRA-differentiated HL-60 neutrophils
were transiently transfected with control siRNA or
siRNA to Mal or MyD88 (all at 40 nM) or were
treated with the indicated compounds (LY294002
or LY303511, 25 mM; C5aRA or iC5aRA control,
1 mM; anti-TLR2mAb or isotype control, 10 mg/ml).
The cells were used in assays of Pg killing (A) and
phagocytosis (B) or in assays of PI3K activation (C)
and cytokine release (D). In (B), cytochalasin D
(CytD) was used as negative control for phagocy-
tosis. In (C) and (D), the horizontal dashed lines
indicate baseline levels of PI3K activation and
cytokines determined on unstimulated cells.
(E) Pg-stimulated lysates of ATRA-differentiated
HL-60 or primary neutrophils were immunopre-
cipitated with antibodies to TLR2 or Mal and were
probed with antibodies to PI3K, Mal, and TLR2. Pg
stimulation was carried out at a MOI equal to 10:1
and for 15 min. Data are means ±SD ([A] and [D],
n = 5; [B] and [C], n = 3). All experiments were
performed two times or more yielding similar
results. *p < 0.01 compared with untreated con-
trol. IB, immunoblotting; IP, immunoprecipitation;
WCL, whole cell lysates. See also Figure S5.
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analogous to those of Pg.
TGF-b1 is a pluripotent cytokine with complex and context-
dependent regulatory effects on inflammation (Wahl, 1994;
Yang et al., 2010), including ubiquitination and negative regula-
tion of MyD88 signaling (Lee et al., 2011; Naiki et al., 2005) as
well as promotion of neutrophil recruitment and activation
(Wahl, 1994). The augmented production of TGF-b1 by Pg-stim-
ulated neutrophils in a C5aR/TLR2-dependent manner promp-
ted us to hypothesize and show that this cytokine mediated
the C5aR/TLR2-dependent ubiquitination and degradation of
MyD88 via the E3 ubiquitin ligase Smurf1.
Themechanism bywhichMyD88mediates neutrophil killing of
Pg may not necessarily be related to MyD88-dependent tran-
scriptional programs. The MyD88-IRAK4 pathway was shown
to mediate TLR-triggered neutrophil exocytosis (Brzezinska
et al., 2009) and to control bacterial killing (Suzuki et al., 2002).
Further research is warranted to determine whether such mech-
anism also operates for the control of Pg. Although MyD88 also
participates in the induction of the neutrophil oxidative burst
(Miletic et al., 2007), thismechanism is unlikely to explain the anti-
microbial effect of MyD88 against Pg. This is because Pg is quite
resistant to oxidative burst killing by neutrophils (Hajishengallis
et al., 2008; Mydel et al., 2006), although in gingival epithelial
cells, where this bacterium can reside intracellularly, Pg inhibits
the long-term production of reactive oxygen species despite an
early activation of the oxidative response (Choi et al., 2013).
In stark contrast to MyD88, Mal acted as a critical component
of an immune-evasive and proinflammatory pathway acting
downstream of the C5aR-TLR2 crosstalk and upstream of
PI3K (Figure 7). This MyD88-independent proinflammatory
PI3K pathway could be activated by Pg in neutrophils but not
in macrophages. Although Mal can mediate MyD88-indepen-
dent activation of PI3K also in macrophages, this activity strictlyCell Hrequires TLR2/6 signaling and cannot be mediated by TLR2/1
agonists (Santos-Sierra et al., 2009) such as Pg (Jain et al.,
2013). The involvement of PI3K in the evasion of phagocytosis
by Pg was an unexpected finding, since PI3K is generally
thought to promote phagocytic function (Hannigan et al.,
2004). However, PI3K activation by high concentrations of C5a
(100 nM) leads to inhibition of phagocytosis in neutrophils (Morris
et al., 2011). Therefore, high C5a levels, such as those generated
by Pg through the enzymatic action of its gingipains (Liang et al.,
2011; Wang et al., 2010), could induce altered PI3K signaling
that inhibits rather than promotes phagocytosis. Indeed, PI3K
signaling activated by Pg-induced C5aR/TLR2 crosstalk in-
hibited RhoA activation and actin polymerization, thereby ac-
counting for the observed inhibition of phagocytosis (Figure 7).
In the murine periodontal tissue, the capacity of Pg to colonize
and mediate dysbiosis required functional C5aR, TLR2, and
PI3K—that is, the same key molecules involved in the manipula-
tion of neutrophils (Figure 7), although additional cell types in the
periodontal environment express the implicated molecules and
might also be affected by Pg. For instance, Pg was shown to
activate and exploit PI3K signaling also in gingival epithelial cells,
where the pathogen suppresses apoptosis in a PI3K-dependent
manner to enhance its intracellular persistence (Yilmaz et al.,
2004). Moreover, in coinfection experiments in the chamber
model, bystander F. nucleatum bacteria acquired resistance to
neutrophil killing as long as C5aR, TLR2, and PI3K were all func-
tional. These findings attest to the predictive power of the model
proposed (Figure 7).
It is increasingly acknowledged that periodontitis is caused by a
synergistic anddysbiotic community of pathobionts rather thanby
select ‘‘periodontal pathogens’’ as traditionally thought (Abusleme
et al., 2013;Hajishengallis and Lamont, 2012). In such community,
the role of Pg is likely to tip the balance from homeostasis to
dysbiosis, upon which commensal bacteria can opportunisticallyost & Microbe 15, 768–778, June 11, 2014 ª2014 Elsevier Inc. 775
Figure 7. Model of Pg Subversion of Neutrophils Leading to Dysbi-
otic Inflammation
Pg coactivates TLR2 andC5aR in neutrophils, and the resulting crosstalk leads
to ubiquitination and proteasomal degradation of MyD88, thereby inhibiting a
host-protective antimicrobial response. This activity requires C5aR/TLR2-
dependent release of TGF-b1 (Figure S2J), which mediates ubiquitin-protea-
some degradation of MyD88 via the E3 ubiquitin ligase Smurf1. Moreover, the
C5aR-TLR2 crosstalk activates PI3K, which prevents phagocytosis through
inhibition of RhoA activation and actin polymerization, while stimulating an
inflammatory response. In contrast to MyD88, Mal is a component of the
subversive pathway acting upstream of PI3K. The integrated mechanism
provides ‘‘bystander’’ protection to otherwise susceptible bacterial species
and promotes polymicrobial dysbiotic inflammation in vivo.
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Uncoupling Bacterial Clearance from Inflammationmediate destructive inflammation as pathobionts (Hajishengallis,
2014; Jiao et al., 2013). The dissected subversive mechanism of
Pg is therapeutically important, as it offers potentially promising
targets (C5aR, TLR2, Mal, and PI3K) for intervention against peri-
odontal dysbiosis and inflammation.
In conclusion, the uncoupling of bacterial clearance from
inflammation is a mechanism whereby keystone pathogens
can contribute to the persistence of inflammophilic communities
that drive dysbiotic inflammatory diseases. In general, the
targeting of pathobiotic microbial communities through host
modulation therapy is likely to be a more effective strategy to
treat polymicrobial inflammatory diseases than traditional direct
antimicrobial approaches, especially since mucosal keystone




All reagents used, including mammalian cells and bacterial and mouse strains,
are described in the Supplemental Experimental Procedures, together with776 Cell Host & Microbe 15, 768–778, June 11, 2014 ª2014 Elsevierdescriptions of standard techniques (e.g., real-time PCR, siRNA transfection,
and immunoprecipitation).
Subcutaneous Chamber Model
The mouse chamber model was previously described (Burns et al., 2010;
Mydel et al., 2006). Briefly, a surgical-grade titanium coil chamber was
implanted subcutaneously in the dorso-lumbar region of each mouse. After
a 7 day healing period, bacteria (109 CFU in 0.1 ml PBS) were injected into
the chambers with or without inhibitors or control compounds, and the mice
were euthanized at different time points (2–24 hr postinoculation). Chamber
fluid was aspirated and divided into aliquots that were used for enumeration
of recovered CFU (after anaerobic growth on blood agar plates), analysis of
recruited cells, and assessment of cytokine responses by ELISA. Kana-
mycin-Vancomycin blood agar plates were used to grow bacteria in coinfec-
tion experiments using F. nucleatum (susceptible to kanamycin and resistant
to vancomycin) and Pg (resistant to kanamycin and susceptible to vancomy-
cin). All mouse experimental procedures described in this study have been
approved by the Institutional Animal Care and Use Committee, in compliance
with established federal and state policies.
Killing Assay
Neutrophil-Pg suspensions (multiplicity of infection [MOI] = 1:1) were incu-
bated at 37C and 5% CO2 for 2 hr, at which time the neutrophils were lysed,
and viable CFU were enumerated after anaerobic culture on blood agar plates.
The killing index was calculated according to the formula: [(CFU in the absence
of neutrophilsCFU in the presence of neutrophils)/ CFU in the absence of
neutrophils] 3 100.
Oxidative Burst Assay
Neutrophils in glucose-containing HBSS (Life Technologies) were preincu-
bated at 37C for 15 min with 100 mM 20,70-dichlorofluorescin diacetate (Life
Technologies) in microtiter culture plates (2 3 105 cells/well). The samples
were then incubated with Pg (MOI = 1:1) at 37C for 15 min (Hajishengallis
et al., 2008). The fluorescent signal resulting from the oxidation of 20,70-dichlor-
ofluorescin into dichlorofluorescein was measured in relative fluorescence
units on a microplate fluorescence reader (BioTek) with excitation/emission
wavelength settings of 485/530 nm.
Phagocytosis
ATRA-differentiated HL-60 neutrophils were incubated at 37C with Syto9-
labeled Pg (MOI = 10:1) for 30 min. After cell washing to remove nonadherent
bacteria, extracellular fluorescence (representing attached but not internalized
bacteria) was quenched with 0.2% trypan blue. The cells were washed again,
fixed, and analyzed by flow cytometry (% positive cells for Syto9-Pg andmean
fluorescence intensity). The phagocytic indexwas calculated using the formula
(% positive cells3mean fluorescence intensity)/100. A similar procedure was
followed to measure in vivo phagocytosis of Pg, in which case Syto9-labeled
Pg was injected into the implanted chambers. The chamber contents were
harvested 2 hr postinoculation for processing and flow cytometry as above.
Bacterial Colonization
The levels of Pg colonization and the number of total bacteria in the periodontal
tissue were determined using quantitative real-time PCR of the ISPg1 gene
(Pg) and the 16S rRNA gene (total bacteria) (Hajishengallis et al., 2011; McIn-
tosh and Hajishengallis, 2012). Details are given in Supplemental Experimental
Procedures.
Cell Activation Assays
The activation of PI3K (Tyr phosphorylation of p85 subunit) was determined
using a colorimetric cell-based ELISA kit (Active Motif). To determine
RhoA activation, stimulated neutrophil lysates (10 mg) were subjected to the
G-LISA RhoA activation assay (Cytoskeleton). In both assays, the cells were
stimulated with Pg (MOI = 10:1) for times shown in figure legends.
Actin Polymerization
Neutrophils were incubated with Pg (MOI = 10:1) for up to 60 min and F-actin
levels were determined by phalloidin staining. Specifically, following washing
in ice-cold PBS, the cells were fixed with 4% formaldehyde (10 min),Inc.
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gated phalloidin (2 mg/ml; 30 min). Rhodamine fluorescence was measured
spectrofluometrically.
FRET
Upon stimulation for 10 min at 37C with Pg (MOI = 10:1), neutrophils were
labeled with a mixture of Cy3-conjugated (donor) and Cy5-conjugated
(acceptor) antibodies, as indicated in Figure 2E. The cells were washed and
fixed, and energy transfer between various donor-acceptor pairs was calcu-
lated from the increase in donor fluorescence after acceptor photobleaching.
Statistical Analysis
Data were evaluated by analysis of variance (ANOVA) and the Dunnett multi-
ple-comparison test using the InStat program (GraphPad). Where appropriate
(comparison of two groups only), two-tailed t tests were performed. If SD were
significantly different among groups, nonparametric tests were used (Mann-
Whitney test for comparison of two groups; Kruskal-Wallis nonparametric
ANOVA and multiple comparisons test for comparison of three groups or
more). p < 0.05 was taken as the level of significance.
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